FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server  |   User: [n/a]

407317001: Adalimumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module Reference Sets
2151148012 Adalimumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core GB English: Preferred (foundation metadata concept)
2158924011 Adalimumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core GB English: Preferred (foundation metadata concept)
789171000172111 adalimumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept) Belgian French language reference set (foundation metadata concept): Preferred (foundation metadata concept)
789181000172114 adalimumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept) Belgian Dutch language reference set (foundation metadata concept): Preferred (foundation metadata concept)

0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adalimumab (substance) Is a Monoclonal antibody agent false Inferred relationship Some
Adalimumab (substance) Is a Anti-rheumatic agent false Inferred relationship Some
Adalimumab (substance) Is a Tumor necrosis factor alpha inhibitor true Inferred relationship Some
Adalimumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Adalimumab (substance) Has disposition (attribute) Tumor necrosis factor alpha inhibitor (disposition) true Inferred relationship Some
Adalimumab (substance) Is a Immunologic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Adalimumab 40mg injection solution 0.8mL prefilled syringe Has active ingredient False Adalimumab (substance) Inferred relationship Some
Product containing adalimumab (medicinal product) Has active ingredient True Adalimumab (substance) Inferred relationship Some 1
Adalimunab 40mg/mL injection solution 1mL prefilled syringe Has active ingredient False Adalimumab (substance) Inferred relationship Some
Adalimumab therapy (procedure) Direct substance True Adalimumab (substance) Inferred relationship Some 2
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe Has precise active ingredient False Adalimumab (substance) Inferred relationship Some 1
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe Has basis of strength substance (attribute) False Adalimumab (substance) Inferred relationship Some 1
Product containing adalimumab in parenteral dose form (medicinal product form) Has active ingredient True Adalimumab (substance) Inferred relationship Some 1
Product containing only adalimumab (medicinal product) Has active ingredient True Adalimumab (substance) Inferred relationship Some 1
Adalimumab only product in parenteral dose form Has active ingredient True Adalimumab (substance) Inferred relationship Some 1
Adalimumab 50 mg/mL solution for injection Has basis of strength substance (attribute) True Adalimumab (substance) Inferred relationship Some 1
Adalimumab 50 mg/mL solution for injection Has precise active ingredient True Adalimumab (substance) Inferred relationship Some 1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Adalimumab (substance) Inferred relationship Some 1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Adalimumab (substance) Inferred relationship Some 1

Reference Sets

Belgian subset for POC FHIR, causative agent, no drug

Back to Start